Studies were undertaken to determine the possible role of enteric bact
eria in the postmortem bioconversion of the nitrobenzodiazepines fluni
trazepam, clonazepam, and nitrazepam. Flunitrazepam, clonazepam, and n
itrazepam were completely metabolized in blood in the presence of eigh
t species of enteric bacteria to their respective 7-amino-metabolites.
The rates of metabolism, at 37 degrees C, ranged from 0.1 ng/mL/min f
or Streptococcus faecalis to 8.8 ng/mL/min for Clostridium perfringens
. The rate of conversion was reduced to 87% by a combination of 0.7% (
w/v) sodium fluoride and potassium oxalate, and almost completely inhi
bited (96%) by 1% (w/v) sodium fluoride. pH had variable effects on th
e rate of metabolic bioconversion of nitrobenzodiazepines, while incre
asing temperatures were found to generally increase the rate of nitrob
enzodiazepine bioconversion. These data support the proposal that bact
eria may mediate postmortem bioconversion of the nitrobenzodiazepines.